Courtney Andersen studies the role of estrogen receptor-alpha in ovarian cancer.
Chris Barnes investigates the structural details by which transcription factor activity regulates RNA Polymerase II during the universal process of eukaryotic gene expression.
Soma Jobaggy studies nitrated fatty acid pharmacology and the antioxidant response in hypertensive end-organ damage.
Allison Nagle studies growth factor receptor signaling in breast cancer.
Seungwon Kim, MD
Assistant Professor, Otolaryngology
EEI, Suite 500 200 Lothrop St.
Pittsburgh, PA 15213

Phone: 412-802-6393

Fax: 412-647-2080

Columbia University (BS)
SUNY / Buffalo (MA)
SUNY HSC at Syracuse (MD)       
SUNY HSC at Syracuse (Internship / Residency)
M.D. Anderson Cancer Center (Fellowship)

Research Areas
Cancer Pharmacology
Photo of Seungwon Kim, MD

Important Publications
Aassero V, Branstetter B, Shuai Y, Gibson M, Lai SY, Kim S, Grandis JR, Ferris RL, Johnson JT, Argiris AE. Response assessment by combined PET/CT scan versus CT scan alone in patients with locally advanced head and neck cancer treated with chemoradiotherapy. Ann Oncol, accepted for publicaion, April 2010.
Kim S. Animal models of cancer in the head and neck region. Clinical Exp Otorhinolaryngol. 2009 Jun;2(2):55-60. Epub 2009 Jun 27
Dunkleberger J, Rhee D, Kim S, Ferguson B. Video rigid laryngeal endoscopy compared to laryngeal mirror examination: an assessment of patient comfort and clinical visualization. Laryngoscope 2009 Feb; 119(2):269-71
Deleyiannis FW-B, Rogers C, Ferris RL, Lai S, Kim S, Johnson J. Reconstruction of the through-and-through anterior mandibulectomy defect: Indications and limitations of the double-skin paddle fibular free flap. Laryngoscope 2008 Aug; 118(8):1329-34.
Kim S, Grandis JR, Rinaldo A, Takes RP, Ferlito A. Emerging Perspectives in Epidermal Growth Factor Receptor Targeting in Head and Neck Cancer. Head & Neck 2007 Mar 30;5:667-674.


1/10/2019 12:00 PM Pharmacology & Chemical Biology Seminar Series
Mitchell Lazar, M.D., Ph.D.

1/17/2019 12:00 PM Pharmacology & Chemical Biology Seminar Series
Mark Jay Shlomchik, MD, PhD

1/19/2019 12:00 PM Pharmacology & Chemical Biology Seminar Series
Mitchell Lazar, MD, PhD

Pharmacology and Chemical Biology Event Calendar

Program Achievements

Molecular Pharmacology Graduate Program Ranked #2 in National Research Council Rankings

Outcomes:  Time to disseration, last five graduating clasess:  4.5 years, Completion Rate: 84.8%

Ranked #12 in National of Institute of Health funding of departments of Pharmacology

Ranked in the top 15 in funding for twenty two consecutive years

Back to Top